Related Experiment Video
Updated: Jun 30, 2025

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.3K
Preterm birth: A neuroinflammatory origin for metabolic diseases?
Sihao Diao1,2,3, Chao Chen2,3, Alexandre Benani4
1Université Paris Cité, Inserm, NeuroDiderot, 75019, Paris, France.
Brain, Behavior, & Immunity - Health
|March 21, 2024
Summary
Preterm birth complications may increase later-life metabolic disease risk. Encephalopathy of prematurity (EoP) neuroinflammation could be a key factor, impacting energy control and HPA axis development.
Area of Science:
- Neonatal Medicine
- Developmental Biology
- Metabolic Disease Research
Background:
- Preterm birth and complications are rising.
- The "developmental origins of health and disease" concept links early life events to later health outcomes.
- Encephalopathy of prematurity (EoP) is a condition affecting premature infants.
Purpose of the Study:
- To propose encephalopathy of prematurity (EoP) as a novel risk factor for metabolic diseases.
- To explore the link between preterm birth, EoP-related neuroinflammation, and metabolic disease development.
- To investigate the underlying mechanisms of developmental programming in metabolic disease.
Main Methods:
- Review of epidemiological evidence linking preterm birth to metabolic diseases.
- Discussion of potential synergistic roles of preterm birth and EoP neuroinflammation.
- Exploration of theoretical mechanisms involving energy control and the HPA axis.
Main Results:
- Epidemiological data suggest a correlation between preterm birth and metabolic diseases.
- EoP-induced neuroinflammation is hypothesized to contribute to metabolic dysregulation.
- Developmental programming of energy homeostasis and HPA axis may be implicated.
Conclusions:
- Encephalopathy of prematurity (EoP) represents a potential early life risk factor for pediatric and adult metabolic diseases.
- Neuroinflammation from EoP may interact with preterm birth to promote metabolic disease development.
- Further research into developmental programming mechanisms is warranted.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
157
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
157
Pathophysiology of Diabetes
927
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
927

